Achaogen (AKAO) Announces Positive Results in Phase 3 cUTI and CRE Clinical Trials of Plazomicin -- EPIC registration trial successfully achieves FDA primary endpoints in patients with complicated urinary tract infections (cUTI) -- http://investors.achaogen.com/releasedetail.cfm?ReleaseID=1003671